We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

ALCOR Scientific Inc.

ALCOR Scientific develops and manufactures proprietary devices for the clinical diagnostics and enteral feeding devic... read more Featured Products: More products

Download Mobile App




Availability Expanded for CE-Marked Erythrocyte Sedimentation Rate Analyzer

By LabMedica International staff writers
Posted on 13 Aug 2014
Print article
Alcor\'s iSED Erythrocyte Sedimentation Rate Analyzer
The iSed Erythrocyte Sedimentation Rate Analyzer (Photo courtesy of ALCOR Scientific Inc.)
An advanced technology erythrocyte sedimentation rate (ESR) analyzer, that delivers results in seconds using small sample, is now available globally.

ALCOR Scientific, Inc. (Smithfield, RI, USA), provider of in vitro diagnostic analyzers and devices for enteral nutrition delivery, has expanded availability of its iSED system for ESR testing to meet growing demand for this advanced technology. Designed, manufactured, and initially launched late 2012 in the USA, the iSED is CE-marked and now available globally, through distributors in Europe, Asia, Africa, South America and North America.

iSED provides accurate, efficient, automated ESR testing – one of the most widely used lab tests worldwide, yet historically one of the most time-consuming and cumbersome to perform. It transforms ESR testing by employing patented technology that delivers accurate results in 20 seconds using a blood sample of just 100 µL, especially important in working with pediatric and geriatric patients. The iSED has a throughput of up to 180 samples per hour, made possible by its random access, continuous feed operation. The system tests samples directly from standard EDTA tubes, reducing both testing costs and contaminated waste. With its closed tube sampling and no disposables required, the iSED greatly speeds processes and improves efficiency, as well as safety for lab clinicians.

The iSED’s high degree of accuracy is enabled by the use of quantitative photometry to measure, in a controlled environment, the formation of the red cell aggregates (Rouleaux) in the most critical phase of the red cell sedimentation. This technology ensures that results obtained, unaffected by variables such as mixing and temperature, accurately reflect the patient’s inflammation status.

“The iSED’s rapid adoption is a testament to its ability to facilitate patient testing through a cost-effective and user-friendly solution that streamlines lab processes,” said Carlo Ruggeri, ALCOR CEO and founder, “Alcor looks forward to introducing new, innovative diagnostic and medical device products driven by the same principles.”

The iSED was recently featured at the American Association of Clinical Chemistry (AACC) Annual Meeting and Expo in Chicago (IL, USA), July 29–31, 2014.

Related Links:

ALCOR Scientific


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Benchtop Cooler
PCR-Cooler & PCR-Rack
New
TRAb Immunoassay
Chorus TRAb
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The breakthrough could result in a higher success rate using a simple oral swab test before IVF (Photo courtesy of Shutterstock)

POC Oral Swab Test to Increase Chances of Pregnancy in IVF

Approximately 15% of couples of reproductive age experience involuntary childlessness. A significant reason for this is the growing trend of delaying family planning, a global shift that is expected to... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.